Maternus-Kliniken AG buy krebskrebs
Start price
27.06.23
/
50%
€1.37
Target price
27.06.24
€1.65
Performance (%)
27.01%
End price
28.06.24
€1.74
Summary
This prediction ended on 28.06.24 with a price of €1.74. The prediction had a final performance of 27.01%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Maternus-Kliniken AG | 26.437% | 26.437% | 65.414% |
iShares Core DAX® | 1.395% | -0.272% | 17.642% |
iShares Nasdaq 100 | 2.287% | 6.912% | 37.651% |
iShares Nikkei 225® | 1.617% | 3.038% | 12.910% |
iShares S&P 500 | 0.659% | 3.687% | 29.434% |
Comments by krebskrebs for this prediction
In the thread Maternus-Kliniken AG diskutieren
Buy mit Kursziel 1,65
In the thread Trading Maternus-Kliniken AG
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten